Differential and diagnostic, predictive and therapeutic value of test with clomifene in men with a Hypogonadizm
https://doi.org/10.14341/probl201662135-37
Abstract
Aim.
In the real research test with an antiestrogen clomifene is offered for differential diagnostics of potential reversibility of a hypogonadism.
Material and methods.
After initial determination of levels of testosterone and LH, to 55 men with a hypogonadism clomifene citrate of 50 mg orally daily in the morning for 10 days was administrated. Levels of testosterone and LH repeatedly were defined on the 11th day.
Results.
The carried-out test with clomifene eliminated a hypogonadism at 85,5% of patients, thus the effect remained at 40%. The test was safe, at one of men of side effects it wasn’t noted. For patients with negative result of test (preservation of a hypogonadism) administration of preparations of testosterone was recommended.
Conclusions.
Test allows not only to differentiate reversibility of a hypogonadism, but also in some cases completely to eliminate it.
About the Authors
Roman Viktorovich Rozhivanov
Endocrinology Research Centre
Russian Federation
MD, PhD, Senior research associate department of Andrology and Urology
Russian Federation
MD, PhD, Senior research associate department of Andrology and Urology
Dmitriy Gennad'evich Kurbatov
Endocrinology Research Centre
Russian Federation
MD, PhD, Professor, Head of department of Andrology and Urology
Russian Federation
MD, PhD, Professor, Head of department of Andrology and Urology
Nataliya Sergeevna Kravtsova
Endocrinology Research Centre
Russian Federation
Russian Federation
PhD student department of Andrology and Urology
References
1. Андрология. Мужское здоровье и дисфункция репродуктивной системы./ Под общ. ред. Нишлага Э., Бере Г.М. — М.; 2005. — 554 с. [Andrology. Men’s health and reproductive system dysfunction. Ed. by Nishlag E, Bere GM. Moscow; 2005. 554 p. (In Russ.)].
2. Роживанов Р.В., Шурдумова Б.О., Парфенова Н.С., Савельева Л.В. Комплексный подход к лечению ожирения и метаболического синдрома у мужчин. // Ожирение и метаболизм. — 2009. — Т. 6. — №4 — С. 38-41. [Rozhivanov RV, Shurdumova BO, Parfenova NS, Savel’eva LV. Kompleksnyy podkhod k lecheniyu ozhireniyai metabolicheskogo sindroma u muzhchin. Obesity and metabolism. 2009;6(4):38-41. (In Russ.)]. doi: 10.14341/2071-8713-4877.
3. Роживанов Р.В. Эффективная терапия и ошибки в лечении эндокринных нарушений в андрологии / В кн.: Эндокринология. Фармакотерапия без ошибок. Под ред. академика РАН и РАМН Дедова И.И., академика РАМН Мельниченко Г.А. — М.; 2013. — с. 615-625. [Rozhivanov RV. Effektivnaya terapiya i oshibki v lechenii endokrinnykh narusheniy v andrologii. In: Endokrinologiya. Farmakoterapiya bez oshibok. Ed by Dedov I.I., Mel’nichenko G.A. Moscow; 2013. p. 615-625. (In Russ.)].
4. Дедов И.И., Калинченко С.Ю. Возрастной андрогенный дефицит у мужчин. — М.: Практическая медицина; 2006. – 240 c. [Dedov II, Kalinchenko SY. Vozrastnoy androgennyy defitsit u muzhchin. Moscow: Prakticheskaya meditsina; 2006. 240 p. (In Russ.)].
Supplementary files
Review
For citations:
Rozhivanov R.V., Kurbatov D.G., Kravtsova N.S. Differential and diagnostic, predictive and therapeutic value of test with clomifene in men with a Hypogonadizm. Problems of Endocrinology. 2016;62(1):35-37. https://doi.org/10.14341/probl201662135-37
Views:
4825
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
